NMDA receptor antagonist, selective for NR1/NR2A (pIC50
= 5.4) over NR1/NR2B.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
Bettini et al.
Direct pharmacological monitoring of the developmental switch in NMDAR subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist.
McKay et al.
The citations listed below are publications that use Tocris products. Selected citations for TCN 213 include:
Showing Results 1 - 2 of 2